Use of social media for pharmacovigilance activities: key findings and recommendations from the Vigi4Med project

B Audeh, F Bellet, MN Beyens, A Lillo-Le Louët… - Drug Safety, 2020 - Springer
The large-scale use of social media by the population has gained the attention of
stakeholders and researchers in various fields. In the domain of pharmacovigilance, this …

Guardrails for avoiding harmful medical product recommendations and off-label promotion in generative AI models

D Lopez-Martinez - arXiv preprint arXiv:2406.16455, 2024 - arxiv.org
Generative AI (GenAI) models have demonstrated remarkable capabilities in a wide variety
of medical tasks. However, as these models are trained using generalist datasets with very …

[HTML][HTML] Validation approaches for computational drug repurposing: a review

M Pillai, D Wu - AMIA Annual Symposium Proceedings, 2023 - ncbi.nlm.nih.gov
Drug discovery and development is a cost and time burdensome process that has stagnated
the entry of new drugs into the market. The traditional process for drug development can …

[PDF][PDF] Trustworthiness in Medical Product Question Answering by Large Language Models

D Lopez-Martinez - 2024 - genai-evaluation-kdd2024.github.io
Large language models (LLMs) have achieved remarkable progress in recent years. These
models have the capability to answer complex questions about medical disorders, their …

Exploiting OHC data with tensor decomposition for off-label drug use detection

M Zhao, CC Yang - 2018 IEEE International Conference on …, 2018 - ieeexplore.ieee.org
Off-label drug use is an important healthcare topic as it is quite common and sometimes
inevitable in medical practice. Though gaining information about off-label drug uses could …

[图书][B] Accelerating Drug Development with Health-Consumer-Contributed Data and Heterogeneous Network Mining

M Zhao - 2019 - search.proquest.com
New drug development is a time-consuming, high-investment, and high-risk process. It
usually takes more than ten years to bring a new medication to market and costs the …